CK-2-68
CK-2-68 is an inhibitor for complex III in protozoan mitochondrial respiratory chain, by targeting the alternative NADH dehydrogenase (NDH2) of the malarial parasite Plasmodium. CK-2-68 exhibits antimalaria efficacy, that inhibits Plasmodium falciparum infected erythrocytes with an IC50 of 40 nM[1].
Product Specifications
CAS Number
1361004-87-6
Product Name Alternative
N-Docosahexaenoyl ethanolamine (DHEA); Docosahexaenoyl ethanolamide
UNSPSC
12352005
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ck-2-68.html
Purity
98.91
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
O=C1C(C)=C(NC2=C1C=CC(Cl)=C2)C3=CC=C(C=C3)CC4=CC=C(C=C4)OC(F)(F)F
Molecular Formula
C24H17ClF3NO2
Molecular Weight
443.85
References & Citations
[1]Esser L, et al., Structure of complex III with bound antimalarial agent CK-2-68 provides insights into selective inhibition of Plasmodium cytochrome bc1 complexes. J Biol Chem. 2023 Jul;299 (7) :104860.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![TBX3 Mouse Monoclonal Antibody [Clone ID: OTI8G5]](https://cdn.genprice.uk/products/937/68dd18bb061270361e908aac/imageurl/cf811209.webp)
BNC682993-500 1x 500 µL
Renal Cell Carcinoma (Carbonic Anhydrase IX) (CA9/2993R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682759-500 1x 500 µL
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 